Ruth A Baxter

Deceased

from Omaha, NE

Get Report

Also known as:

Connected to:

Ruth Baxter Phones & Addresses

view source

Location:

13609 California St, Omaha, NE 68154

Industry:

Staffing And Recruiting

Work:

Aureus Medical Group
Ct and Mr Technologist

view source

view source

view source

view source

view source

view source

view source

Nucleic Acid Delivery Using Modified Chitosans
view source
US Patent:

20120295355, Nov 22, 2012
Filed:

Mar 12, 2012
Appl. No.:

13/417992
Inventors:

Shenda Baker - Upland CA, US
William P. Wiesmann - Washington DC, US
Ruth Baxter - Los Angeles CA, US
Snezna Rogelj - Socorro NM, US
International Classification:

C08B 37/08
C12N 15/85
C12N 15/87
US Classification:

435455, 536 20
Abstract:

The present invention is directed to the delivery of nucleic acids in a non-viral vector to cells by positively charged chitosan derivatives, including but not limited to chitosan-arginine, chitosan-lysine and chitosan-histidine.

Methods And Compositions For Treating Wounds Utilizing Chitosan Compounds
view source
US Patent:

20130210761, Aug 15, 2013
Filed:

Apr 6, 2011
Appl. No.:

13/639560
Inventors:

Shenda Baker - Upland CA, US
William P. Wiesmann - Washington DC, US
Ruth Baxter - Los Angeles CA, US
Assignee:

SYNEDGEN, INC. - Claremont CA
International Classification:

A61K 31/722
US Classification:

514 54
Abstract:

Described herein are methods of treating wounds, the method comprising administering to a subject an effective amount of a composition comprising a soluble or derivatized chitosan wherein the soluble or derivatized chitosan when administered contacts the wound, thereby treating the wound.

Gapr-1 Methods
view source
US Patent:

20110059069, Mar 10, 2011
Filed:

Sep 22, 2006
Appl. No.:

11/992464
Inventors:

Ruth Baxter - Los Angeles CA, US
Humphrey Gardner - Salem MA, US
International Classification:

A61K 39/395
C12N 5/077
G01N 33/53
G01N 33/00
A61K 38/16
C12N 5/071
A01N 1/02
A61P 35/00
US Classification:

4241331, 435375, 4241301, 4241391, 436 86, 436 94, 435 721, 800 3, 514 193, 435374, 435 11
Abstract:

Methods of treatment, diagnosis and screening related to GAPR-1 are disclosed.

Derivatized Polyglucosamines For Delivery Of Small Molecules, Peptides, And Proteins
view source
US Patent:

20200061192, Feb 27, 2020
Filed:

May 1, 2019
Appl. No.:

16/400808
Inventors:

- Claremont CA, US
Ruth Baxter - Los Angeles CA, US
William P. Wiesmann - Chevy Chase MD, US
International Classification:

A61K 47/36
A61K 31/203
A61K 31/4166
A61K 38/18
Abstract:

Described herein are compositions comprising a derivatized polyglucosamine and a small molecule, peptide, or protein and related methods of use, e.g., to deliver a small molecule, peptide, or protein to cells (e.g., cancer cells) or tissues (e.g., mucosal membrane and epithelial membrane), e.g., to treat a disease or condition at a subject.